|
1
|
Intraoperative identification of sentinel lymph nodes by near-infrared fluorescence imaging in patients with breast cancer.
|
Am J Surg
|
2008
|
2.43
|
|
2
|
NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells.
|
Cancer Res
|
2008
|
2.01
|
|
3
|
The relationship between FDG uptake in PET scans and biological behavior in breast cancer.
|
Breast Cancer
|
2007
|
1.23
|
|
4
|
Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas.
|
J Clin Endocrinol Metab
|
2012
|
1.17
|
|
5
|
Correlation of L-type amino acid transporter 1 and CD98 expression with triple negative breast cancer prognosis.
|
Cancer Sci
|
2011
|
1.11
|
|
6
|
Overexpression of p16 and p14ARF is associated with human papillomavirus infection in cervical squamous cell carcinoma and dysplasia.
|
Pathol Int
|
2002
|
1.10
|
|
7
|
Increasing 14-3-3 sigma expression with declining estrogen receptor alpha and estrogen-responsive finger protein expression defines malignant progression of endometrial carcinoma.
|
Pathol Int
|
2005
|
1.09
|
|
8
|
Protein expression, gene amplification, and mutational analysis of EGFR in triple-negative breast cancer.
|
Breast Cancer
|
2012
|
1.06
|
|
9
|
Gastric schwannomas show an obviously increased fluorodeoxyglucose uptake in positron emission tomography: report of two cases.
|
Surg Today
|
2011
|
1.05
|
|
10
|
Two cases of breast cancer with cartilaginous and osseous metaplasia.
|
Breast Cancer
|
2005
|
1.04
|
|
11
|
PKC theta, a novel immunohistochemical marker for gastrointestinal stromal tumors (GIST), especially useful for identifying KIT-negative tumors.
|
Pathol Int
|
2005
|
1.03
|
|
12
|
Aberrant expression of pRb, p16, p14ARF, MDM2, p21 and p53 in stage I adenocarcinomas of the lung.
|
Pathol Int
|
2002
|
1.00
|
|
13
|
Immunohistochemical evaluation for hormone receptors in breast cancer: a practically useful evaluation system and handling protocol.
|
Breast Cancer
|
2006
|
0.99
|
|
14
|
Cellular composition of subacute thyroiditis. an immunohistochemical study of six cases.
|
Pathol Res Pract
|
2002
|
0.98
|
|
15
|
Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer.
|
BMC Cancer
|
2013
|
0.97
|
|
16
|
Increased Rac1 activity and Pak1 overexpression are associated with lymphovascular invasion and lymph node metastasis of upper urinary tract cancer.
|
BMC Cancer
|
2010
|
0.97
|
|
17
|
High expression of Ran GTPase is associated with local invasion and metastasis of human clear cell renal cell carcinoma.
|
Int J Cancer
|
2008
|
0.97
|
|
18
|
Clinicopathological significance of ASC amino acid transporter-2 expression in pancreatic ductal carcinoma.
|
Histopathology
|
2014
|
0.94
|
|
19
|
Immunohistochemical analysis of 14-3-3 sigma and related proteins in hyperplastic and neoplastic breast lesions, with particular reference to early carcinogenesis.
|
Pathol Int
|
2004
|
0.93
|
|
20
|
Keratin 17 expression correlates with tumor progression and poor prognosis in gastric adenocarcinoma.
|
Ann Surg Oncol
|
2012
|
0.92
|
|
21
|
A case of mesenteric cystic lymphangioma in an adult which caused duodenal stenosis after resection.
|
Int J Surg Case Rep
|
2012
|
0.90
|
|
22
|
Immunohistochemical expression of 14-3-3 sigma protein in various histological subtypes of uterine cervical cancers.
|
Pathol Int
|
2004
|
0.90
|
|
23
|
Lymph node lesion in adult-onset Still's disease resembling peripheral T-cell lymphoma: a report of three cases.
|
Int J Surg Pathol
|
2002
|
0.89
|
|
24
|
Expression of L-type amino acid transporter 1 (LAT1) as a prognostic and therapeutic indicator in multiple myeloma.
|
Cancer Sci
|
2014
|
0.88
|
|
25
|
Comparison of evaluations for hormone receptors in breast carcinoma using two manual and three automated immunohistochemical assays.
|
Am J Clin Pathol
|
2007
|
0.88
|
|
26
|
Prevalence, viral load, and physical status of HPV 16 and 18 in cervical adenosquamous carcinoma.
|
Virchows Arch
|
2009
|
0.87
|
|
27
|
Expression of amino acid transporters (LAT1, ASCT2 and xCT) as clinical significance in hepatocellular carcinoma.
|
Hepatol Res
|
2014
|
0.86
|
|
28
|
Up-regulation of a BCL9-related beta-catenin-binding protein, B9L, in different stages of sporadic colorectal adenoma.
|
Cancer Sci
|
2007
|
0.86
|
|
29
|
Diagnostic usefulness of ¹⁸F-FAMT PET and L-type amino acid transporter 1 (LAT1) expression in oral squamous cell carcinoma.
|
Eur J Nucl Med Mol Imaging
|
2013
|
0.86
|
|
30
|
Neoadjuvant weekly paclitaxel with and without trastuzumab in locally advanced or metastatic breast cancer.
|
Anticancer Res
|
2009
|
0.86
|
|
31
|
Comparison of L-type amino acid transporter 1 expression and L-[3-18F]-α-methyl tyrosine uptake in outcome of non-small cell lung cancer.
|
Nucl Med Biol
|
2010
|
0.86
|
|
32
|
Centroblastic and centroblastic/centrocytic lymphoma associated with a prominent epithelioid granulomatous response: a clinicopathologic study of 50 cases.
|
Mod Pathol
|
2002
|
0.85
|
|
33
|
Triple-negative breast cancer: histological subtypes and immunohistochemical and clinicopathological features.
|
Cancer Sci
|
2011
|
0.85
|
|
34
|
Immunological significance of the accumulation of autophagy components in oral squamous cell carcinoma.
|
Cancer Sci
|
2014
|
0.84
|
|
35
|
Luteinizing hormone (LH)-releasing hormone agonist reduces serum adrenal androgen levels in prostate cancer patients: implications for the effect of LH on the adrenal glands.
|
J Androl
|
2012
|
0.84
|
|
36
|
Dilated cardiomyopathy as a presenting feature of Cushing's syndrome.
|
Intern Med
|
2013
|
0.83
|
|
37
|
Immunohistochemical expression of the beta-catenin-interacting protein B9L is associated with histological high nuclear grade and immunohistochemical ErbB2/HER-2 expression in breast cancers.
|
Cancer Sci
|
2007
|
0.83
|
|
38
|
Pathological complete response and prognosis in patients receiving neoadjuvant paclitaxel and trastuzumab with and without anthracyclines for stage II and III, HER2-positive operable breast cancer: a single-institute experience.
|
Anticancer Res
|
2011
|
0.82
|
|
39
|
Progressive transformation of germinal centers: a clinicopathological study of 42 Japanese patients.
|
Int J Surg Pathol
|
2003
|
0.82
|
|
40
|
Local control by breast-conserving surgery with nipple resection.
|
Anticancer Res
|
2005
|
0.82
|
|
41
|
Topoisomerase II alpha expression and the Ki-67 labeling index correlate with prognostic factors in estrogen receptor-positive and human epidermal growth factor type-2-negative breast cancer.
|
Breast Cancer
|
2011
|
0.82
|
|
42
|
Bizarre parosteal osteochondromatous proliferation of the maxilla: a case report.
|
Oral Surg Oral Med Oral Pathol Oral Radiol
|
2012
|
0.82
|
|
43
|
Protein profiling of blood samples from patients with hereditary leiomyomatosis and renal cell cancer by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
|
Int J Mol Sci
|
2012
|
0.81
|
|
44
|
Pathological tumor response to neoadjuvant chemotherapy using anthracycline and taxanes in patients with triple-negative breast cancer.
|
Exp Ther Med
|
2011
|
0.81
|
|
45
|
Immunohistochemical demonstration of 14-3-3 sigma protein in normal human tissues and lung cancers, and the preponderance of its strong expression in epithelial cells of squamous cell lineage.
|
Pathol Int
|
2003
|
0.81
|
|
46
|
Prognostic significance of global grading system of Gleason score in patients with prostate cancer with bone metastasis.
|
BJU Int
|
2009
|
0.81
|
|
47
|
Somatic mutations of the catalytic subunit of cyclic AMP-dependent protein kinase (PRKACA) gene in Japanese patients with several adrenal adenomas secreting cortisol [Rapid Communication].
|
Endocr J
|
2014
|
0.81
|
|
48
|
YM155 reverses rapamycin resistance in renal cancer by decreasing survivin.
|
J Cancer Res Clin Oncol
|
2014
|
0.81
|
|
49
|
Synergistic decline in expressions of p73 and p21 with invasion in esophageal cancers.
|
Cancer Sci
|
2003
|
0.80
|
|
50
|
Preparation of a single prostate needle biopsy specimen for histological diagnosis and RNA analysis.
|
J Urol
|
2006
|
0.79
|
|
51
|
Immunohistological analysis of HPV L1 capsid protein and p16 protein in low-grade dysplastic lesions of the uterine cervix.
|
Pathol Res Pract
|
2010
|
0.78
|
|
52
|
Prognostic significance of L-type amino acid transporter 1 (LAT1) expression in cutaneous melanoma.
|
Melanoma Res
|
2015
|
0.78
|
|
53
|
Breast-conserving surgery following radiation therapy of 50 Gy in stages I and II carcinoma of the breast: the experience at one institute in Japan.
|
Oncol Rep
|
2002
|
0.78
|
|
54
|
Co-expressed type of ER and HER2 protein as a predictive factor in determining resistance to antiestrogen therapy in patients with ER-positive and HER2-positive breast cancer.
|
Oncol Rep
|
2005
|
0.78
|
|
55
|
[L-type amino acid transporter 1 (LAT1)].
|
Nihon Rinsho
|
2012
|
0.78
|
|
56
|
Novel clusters of highly expressed genes accompany genomic amplification in breast cancers.
|
FEBS Lett
|
2007
|
0.78
|
|
57
|
Primary marginal zone B-cell lymphoma of the lymph node resembling plasmacytoma arising from a plasma cell variant of Castleman's disease. A clinicopathological and immunohistochemical study of seven patients.
|
APMIS
|
2002
|
0.77
|
|
58
|
Clinicopathological and immunohistochemical characteristics of esophageal carcinosarcoma.
|
Anticancer Res
|
2009
|
0.77
|
|
59
|
Papillary lesions of the breast diagnosed using core needle biopsies.
|
Exp Ther Med
|
2011
|
0.77
|
|
60
|
Large cell neuroendocrine carcinoma of the lung: a comparison with large cell carcinoma with neuroendocrine morphology and small cell carcinoma.
|
Lung Cancer
|
2005
|
0.76
|
|
61
|
Idiopathic ulcer of the small bowel containing numerous plasma cells: case resembling mucosa-associated lymphoid tissue lymphoma.
|
J Gastroenterol Hepatol
|
2005
|
0.76
|
|
62
|
Low-density lipoprotein and oxysterols suppress the transcription of CTP: Phosphoethanolamine cytidylyltransferase in vitro.
|
Biochim Biophys Acta
|
2010
|
0.76
|
|
63
|
Expression of Amino Acid Transporters (LAT1 and ASCT2) in Patients with Stage III/IV Laryngeal Squamous Cell Carcinoma.
|
Pathol Oncol Res
|
2015
|
0.76
|
|
64
|
Clinicopathological significance of L-type amino acid transporter 1 (LAT1) expression in patients with adenoid cystic carcinoma.
|
Pathol Oncol Res
|
2013
|
0.76
|
|
65
|
Immunohistochemical double staining with estrogen receptor and HER2 on primary breast cancer.
|
Int J Mol Med
|
2003
|
0.75
|
|
66
|
Breast-conserving therapy versus modified radical mastectomy in the treatment of early breast cancer in Japan.
|
Breast Cancer
|
2002
|
0.75
|
|
67
|
Characteristics of Japanese aldosterone-producing adenomas with KCNJ5 mutations.
|
Endocr J
|
2016
|
0.75
|
|
68
|
Stratified mucin-producing intraepithelial lesions (SMILEs) of the uterine cervix are associated with HPV integration.
|
Pathol Int
|
2014
|
0.75
|
|
69
|
Ampullary carcinoma associated with protein-losing gastropathy due to diffuse varioliform gastritis.
|
Hepatogastroenterology
|
2005
|
0.75
|
|
70
|
Recommendations for 'adequate evaluation of hormone receptors' a report of the task force of the Japanese Breast Cancer Society.
|
Oncol Rep
|
2010
|
0.75
|
|
71
|
[Metastatic breast cancer treated with trastuzumab and paclitaxel--a case report with clinically complete response].
|
Gan To Kagaku Ryoho
|
2004
|
0.75
|
|
72
|
Breast pathology slide seminar linked to poster presentations: a new idea to make case presentations in medical conferences more interactive.
|
Breast Cancer
|
2002
|
0.75
|
|
73
|
A patient with classic severe primary hyperparathyroidism in whom both Tc-99m MIBI scintigraphy and FDG-PET failed to detect the parathyroid tumor.
|
Intern Med
|
2004
|
0.75
|
|
74
|
Anaplastic Lymphoma Kinase (ALK) Rearrangement-positive Lung Cancer with Transformation to Pleomorphic Carcinoma.
|
Intern Med
|
2015
|
0.75
|
|
75
|
Immunohistochemical staining patterns of cytokeratins 13, 14, and 17 in oral epithelial dysplasia including orthokeratotic dysplasia.
|
Pathol Int
|
2014
|
0.75
|
|
76
|
Primary liver somatostatinoma.
|
J Gastroenterol Hepatol
|
2003
|
0.75
|
|
77
|
Huge myoid hamartoma of the breast treated with reduction mammaplasty: report of a case.
|
Surg Today
|
2014
|
0.75
|